Clinical Trials at University of New Mexico
As of August 2026, 40 paid clinical trials are recruiting at University of New Mexico, located at DEPT OF RADIOLOGY MSC10 5530, 1 UNIVERSITY OF NEW MEXICO, ALBUQUERQUE, NM 87131-0001, phone (505) 272-0011 in Albuquerque, New Mexico. Active studies at this site cover conditions such as Breast Cancer, Ovarian Cancer and Acute Myeloid Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Albuquerque
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
41 clinical trials at University of New Mexico
·Clear filters·A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Specimens
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Continued Pressure for Alveolar Protection (CPAP Trial)
Trial of Underwater Birth
Opioid Adherence and Support Through Innovative Texting Strategies
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
Follow-up Visit of High Risk Infants
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Wellness, Alcohol, Vitals, and Emotions
Cervical Ripening Balloons for Same-Day Cervical Prep
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Neonatal Platelet Transfusion Threshold Trial
Generic Database of Very Low Birth Weight Infants
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Transformative Research in Diabetic Nephropathy
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Uterine Preservation Via Lifestyle Transformation
Psilocybin for Opioid Use Disorder (OUD)
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Ketogenic Diet and Diabetes Demonstration Project
Effects of Multiple-Session Transcranial Direct Current Stimulation (tDCS) on Behavioral, Physiological, and Electrophysiological Measures With Adults With Autism Spectrum Disorder (ASD)
Parkinson's Foundation PD GENEration Genetic Registry
Common conditions studied in Albuquerque
- Breast Cancer (8 active studies)
- Ovarian Cancer (8 active studies)
- Acute Myeloid Leukemia (7 active studies)
- Endometrial Cancer (7 active studies)
- Malignant Solid Neoplasm (7 active studies)
- Obesity (6 active studies)
Leading research sponsors in Albuquerque
- National Cancer Institute (NCI)
- University of New Mexico
- NRG Oncology
- AstraZeneca
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Albuquerque?
There are approximately 322 recruiting clinical trials in Albuquerque, New Mexico listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Albuquerque pay participants?
Most recruiting trials in Albuquerque compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Albuquerque?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Albuquerque?
The most common conditions under active study in Albuquerque include Breast Cancer (8), Ovarian Cancer (8), Acute Myeloid Leukemia (7), Endometrial Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Albuquerque?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Albuquerque on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Albuquerque?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Albuquerque?
Recruiting research sites in Albuquerque include University of New Mexico Cancer Center, University of New Mexico, Presbyterian Kaseman Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Albuquerque right now?
The largest active categories in Albuquerque are Cancer & tumors (121), Cardiovascular (25), Diabetes & metabolic (22). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of New Mexico?
University of New Mexico is located at DEPT OF RADIOLOGY MSC10 5530, 1 UNIVERSITY OF NEW MEXICO, ALBUQUERQUE, NM 87131-0001. Use the Google Maps link in the intro above to get directions.
How do I contact University of New Mexico?
You can reach University of New Mexico by phone at (505) 272-0011. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.